Cardiovascular Drug Use After AKI Among Hospitalized Patients with a History of Myocardial Infarction: A Population-Based Study
Alejandro Meraz-Muñoz(St. Boniface Hospital), Samuel A. Silver(Queen's University), Nivethika Jeyakumar, Javier A. Neyra(University of Alabama at Birmingham), Edward G. Clark(University of Ottawa), William Beaubien‐Souligny(Centre Hospitalier de l’Université de Montréal), Glenn M. Chertow(Stanford Health Care), Abhijat Kitchlu(University Health Network), Ziv Harel(St. Michael's Hospital), Michael Zappitelli(Unknown), Ron Wald(St. Michael's Hospital), Rahul Chanchlani(McMaster Children's Hospital), Bin Luo, Amit X. Garg(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
|Journal of the American Society of Nephrology|2005|3.4k
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
|Journal of the American Society of Nephrology|2004|2.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k